Prenetics Global: Path To Profitability On Course With Financing Deal

Prenetics Global Limited maintains a buy rating, supported by a $1 billion CVF financing deal to drive customer acquisition and profitability. For FY 2026, I expect PRE to spend at least 50% of its annual revenue ($215 million) on marketing spend, translating to $154.8 million in gross profit. The CVF facility will finance up to 70% of IM8 marketing spend, materially improving PRE's cash efficiency and bottom line. Valuation analysis indicates PRE trades near fair value now, with a potential 74% upside by 2028 if revenue targets and financing execution are achieved.

The growth story of consumer health firm Prenetics Global Limited ( PRE ) continues after it secured $1 billion in growth financing from General Catalyst’s Customer Value Fund (CVF). Shares of the firm are up 157.59% (YoY) and 16.85% (YoY) since